Anocca

Anocca is a biotech company in Södertälje, Sweden, founded in 2014. It has raised $82.8M across 2 rounds, most recently a $46.0M Venture Round in August 2025.

Engineered Immunity

Headquarters
Södertälje
Employees
51–200
Founded
2014
Website
anocca.com
Total Funding
$82.8M
Last Round
$46.0M Venture RoundAug 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Anocca focuses on developing libraries of TCR-T cell therapies for cancers that are particularly difficult to treat. Its activities encompass both the development and manufacture of these therapies, bringing together the creation of TCR-T treatment libraries and the manufacturing work needed to produce them.

Summary

It lists 51–200 employees. It has raised $82.8M in total across 2 rounds, most recently a $46.0M Venture Round in Aug 2025. Investors include AMF.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundAug 2025
$46.0M

Sign up to see all 3 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Anocca on Indexed.vc
<a href="https://indexed.vc/companies/anocca"><img src="https://indexed.vc/api/badge/company/anocca" alt="Anocca on Indexed.vc" width="260" height="76" /></a>